Health Care: Drugs

Acorda Therapeutics Inc (ACOR: NASDAQ)

$31.97 -0.76 | -2.32%
08/31/15 - 04:00 PM ET
Company Income Statement
Dec 2014 Dec 2013 Dec 2012 Dec 2011
Sales 401.48M 336.43M 305.81M 292.24M
Cost of Sales 64.25M 57.07M 48.53M 55.09M
Gross Operating Profit 337.23M 279.36M 257.28M 237.15M
Selling, General, and Administrative Expenses 201.81M 185.54M 168.69M 148.51M
Research & Development 73.47M 53.88M 53.88M 42.11M
Operating Income before D & A (EBITDA) 61.94M 39.94M 34.71M 46.53M
Depreciation & Amortization 16.36M 9.58M 9.11M 11.48M
Interest Income 674.00K 668.00K 552.00K 552.00K
Other Income - Net 232.00K 0.00 -6.00K -18.00K
Special Income / Charges -9.19M 0.00 0.00 0.00
Total Income Before Interest Expenses (EBIT) 37.30M 31.03M 26.15M 35.59M
Interest Expense 9.29M 2.17M 1.88M 3.57M
Pre-Tax Income 28.01M 28.86M 24.27M 32.02M
Income Taxes 10.34M 12.42M -130.69M 1.41M
Minority Interest 0.00 0.00 0.00 0.00
Net Income From Continuing Operations 17.67M 16.44M 154.96M 30.60M
Net Income From Discontinued Operations 0.00 0.00 0.00 0.00
Net Income From Total Operations 17.67M 16.44M 154.96M 30.60M
Extraordinary Income/Losses 0.00 0.00 0.00 0.00
Income From Cum. Effect of Acct. Change 0.00 0.00 0.00 0.00
Income From Tax Loss Carryforward 0.00 0.00 0.00 0.00
Other Gains / Losses 0.00 0.00 0.00 0.00
Total Net Income 17.67M 16.44M 154.96M 30.60M
Normalized Income
(Net Income From Continuing Operations,
Ex. Special Income / Charge)
26.86M 16.44M 154.96M 30.60M
Preferred Dividends
Net Income Available To Common 17.67M 16.44M 154.96M 30.60M
Basic EPS from Continuing Ops. 0.43 0.41 3.93 0.78
Basic EPS from Discontinued Ops. 0.00 0.00 0.00 0.00
Basic EPS from Total Operations 0.43 0.41 3.93 0.78
Basic EPS from Extraordinary Inc. 0.00 0.00 0.00 0.00
Basic EPS from Cum Effect of Accounting Change 0.00 0.00 0.00 0.00
Basic EPS from Tax Loss Carryf'd. 0.00 0.00 0.00 0.00
Basic EPS from Other Gains (Losses) 0.00 0.00 0.00 0.00
Basic EPS, Total 0.43 0.41 3.93 0.78
Basic Normalized Net Income/Share 0.65 0.41 3.93 0.78
EPS fr Continuing Ops. 0.42 0.39 3.84 0.76
EPS fr Discontinued Ops 0.00 0.00 0.00 0.00
EPS fr Total Ops. 0.42 0.39 3.84 0.76
EPS fr Extraord. Inc. 0.00 0.00 0.00 0.00
EPS fr Cum Effect of Accounting Change 0.00 0.00 0.00 0.00
EPS fr Tax Loss Carfd. 0.00 0.00 0.00 0.00
EPS fr Other Gains (L) 0.00 0.00 0.00 0.00
EPS, Total 0.42 0.39 3.84 0.76
Diluted Normalized Net Inc/Shr
(Net Income From Continuing Operations,
Ex. Special Income / Charge)
0.63 0.39 3.84 0.76
Dividends Paid per Share 0.00 0.00 0.00 0.00

Portfolios with ACOR

Latest ACOR Headlines from TheStreet

More Financial News for ACOR

Press Releases for ACOR

See All Press Releases
brokerage partners
connect with Stockpickr
Fan us on FaceBook
Follow us on Twitter